These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11307801)

  • 1. Generation of a humanized, high affinity anti-tissue factor antibody for use as a novel antithrombotic therapeutic.
    Presta L; Sims P; Meng YG; Moran P; Bullens S; Bunting S; Schoenfeld J; Lowe D; Lai J; Rancatore P; Iverson M; Lim A; Chisholm V; Kelley RF; Riederer M; Kirchhofer D
    Thromb Haemost; 2001 Mar; 85(3):379-89. PubMed ID: 11307801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
    Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope location on tissue factor determines the anticoagulant potency of monoclonal anti-tissue factor antibodies.
    Kirchhofer D; Moran P; Chiang N; Kim J; Riederer MA; Eigenbrot C; Kelley RF
    Thromb Haemost; 2000 Dec; 84(6):1072-81. PubMed ID: 11154116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E- and P-selectin.
    He XY; Xu Z; Melrose J; Mullowney A; Vasquez M; Queen C; Vexler V; Klingbeil C; Co MS; Berg EL
    J Immunol; 1998 Jan; 160(2):1029-35. PubMed ID: 9551944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human antibody that binds to the gamma-carboxyglutamic acid domain of factor IX is a potent antithrombotic in vivo.
    Refino CJ; Himber J; Burcklen L; Moran P; Peek M; Suggett S; Devaux B; Kirchhofer D
    Thromb Haemost; 1999 Sep; 82(3):1188-95. PubMed ID: 10494786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A humanized antibody specific for the platelet integrin gpIIb/IIIa.
    Co MS; Yano S; Hsu RK; Landolfi NF; Vasquez M; Cole M; Tso JT; Bringman T; Laird W; Hudson D
    J Immunol; 1994 Mar; 152(6):2968-76. PubMed ID: 8144896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeys.
    Co MS; Baker J; Bednarik K; Janzek E; Neruda W; Mayer P; Plot R; Stumper B; Vasquez M; Queen C; Loibner H
    Cancer Res; 1996 Mar; 56(5):1118-25. PubMed ID: 8640770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insight into how an anti-idiotypic antibody against D3H44 (anti-tissue factor antibody) restores normal coagulation.
    Eigenbrot C; Meng YG; Krishnamurthy R; Lipari MT; Presta L; Devaux B; Wong T; Moran P; Bullens S; Kirchhofer D
    J Mol Biol; 2003 Aug; 331(2):433-46. PubMed ID: 12888350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
    Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
    J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
    Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
    Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.
    Onuma E; Sato K; Saito H; Tsunenari T; Ishii K; Esaki K; Yabuta N; Wakahara Y; Yamada-Okabe H; Ogata E
    Anticancer Res; 2004; 24(5A):2665-73. PubMed ID: 15517871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
    Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments.
    Leung SO; Qu Z; Hansen HJ; Shih LB; Wang J; Losman MJ; Goldenberg DM; Sharkey RM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3106s-3117s. PubMed ID: 10541351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC.
    Hakimi J; Ha VC; Lin P; Campbell E; Gately MK; Tsudo M; Payne PW; Waldmann TA; Grant AJ; Tsien WH
    J Immunol; 1993 Jul; 151(2):1075-85. PubMed ID: 8335891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanization of the murine anti-human CD3 monoclonal antibody OKT3.
    Adair JR; Athwal DS; Bodmer MW; Bright SM; Collins AM; Pulito VL; Rao PE; Reedman R; Rothermel AL; Xu D
    Hum Antibodies Hybridomas; 1994; 5(1-2):41-7. PubMed ID: 7858182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
    Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
    Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of procoagulant activity of extracellular endothelial matrix by anti-tissue factor antibody and the synthetic peptide Arg-Gly-Asp-Val. Experiments with flowing non-anticoagulated human blood.
    Salatti JA; Anton P; Nemerson Y; Sakariassen KS
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):881-90. PubMed ID: 8148480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of human platelet specific functional antibody and its fragments].
    Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.